AIATELLA Raises €2M to Scale AI-Powered Vascular Imaging Technology

Aiatella, a Helsinki-based medtech startup, has raised €2M to expand operations and accelerate R&D across Europe and North America. The round was led by Nordic Science Investments, with participation from Specialist VC, Harjavalta Ventures, Business Finland, and a syndicate of angel investors.

Led by CEO Jack Parker, AIATELLA is developing Automated Image Measurement (AIM) — a multi-modal AI solution that analyzes vascular imaging from MRI, CT, and ultrasound scans. The technology detects and quantifies abnormalities and changes in at-risk patients over time, helping clinicians identify issues earlier and act faster.

By automating what previously took hours into minutes, Aiatella empowers care teams to shift focus from manual analysis to patient care — accelerating workflows while improving outcomes.

The company is currently undergoing medical approval in the UK, France, the U.S., and other key healthcare markets, with early traction building across Europe and North America.